Novel Inhibitors of E. coli RecA ATPase Activity.
The bacterial RecA protein has been implicated as a bacterial drug target not as an antimicrobial target, but as an adjuvant target with the potential to suppress the mechanism by which bacteria gain drug resistance. In order to identify small molecules that inhibit RecA/ssDNA nucleoprotein filament formation, we have adapted the phosphomolybdate-blue ATPase assay for high throughput screening to determine RecA ATPase activity against a library of 33,600 compounds, which is a selected representation of diverse structure of 350,000. Four distinct chemotypes were represented among the 40 validated hits. SAR and further chemical synthesis is underway to optimize this set of inhibitors to be used as antimicrobial adjuvant agents.
Sexton
Jonathan Z
JZ
Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, 27707, USA.
Wigle
Tim J
TJ
He
Qingping
Q
Hughes
Mark A
MA
Smith
Ginger R
GR
Singleton
Scott F
SF
Williams
Alfred L
AL
Yeh
Li-An
LA